Merck Focusing on Combination Vaccine
Manufacturer Stops Sales of Monovalents for Measles, Mumps, Rubella
By David Mitchell
"The combination vaccine is what's recommended, and it's such a significant portion of the orders we see," said Rose. "It's in the best interest of public health to make more of that rather than dedicate manufacturing capacity to monovalents."
Rose said Merck had not decided when, or if, it might make the monovalent vaccines available for sale in the future.
Doug Campos-Outcalt, M.D., M.P.A., who serves as the AAFP's liaison to the CDC's Advisory Committee on Immunization Practices and is a former member of the AAFP Commission on Clinical Policies and Research, said Merck's decision was insignificant in terms of public health. He added, however, that some parents likely will be unhappy.
"The use of the single antigen is pretty limited," he said. "There's no harm if you need one in getting all three. There are some parents out there that want a delayed vaccine schedule. They want the vaccines spread out over a longer period of time and not so many at once. That's a lot of hooey. Alternative schedules have never been proven to be superior."
In December 2008, the Holy See affirmed in Dignitas Personae, that “everyone has the duty to make known their disagreement and to ask that their healthcare system make other types of vaccines available.”
Merck know its not "a lot of hooey" to you!
Write to voice your complaints and send a copy to the CDC
Write to Merck at:
Richard Clark, CEO
Merck & Company
One Merck Drive P.O. Box 100
Whitehouse Station, NJ 08889-0100
Call Merck to complain: 1-800-672-6372
Write to the CDC at:
Thomas Frieden, MD, MPH, Director
Centers for Disease Control
1600 Clifton Rd
Atlanta, GA 30333
Call the CDC to complain: 1-800-232-4636
Want to send a group letter with signatures? PDF form-letter available